Kristal Robert Eugene 4
4 · BioRestorative Therapies, Inc. · Filed Nov 16, 2021
Insider Transaction Report
Form 4
Kristal Robert Eugene
Chief Financial Officer
Transactions
- Award
Stock Option
2021-11-04+10,490→ 10,490 totalExercise: $13.50Exp: 2031-11-04→ Common Stock (10,490 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.